ASTELLAS REIMBURSEMENT CONCIERGE SERVICES
Dead · Cancelled DEAD/REGISTRATION/Cancelled/Invalidated
What this record means
The record shows that “ASTELLAS REIMBURSEMENT CONCIERGE SERVICES” is a cancelled Principal Register registration (status dead) owned by Astellas Pharma Inc., a corporation organized in Japan; the cancellation was entered on September 27 2019 because the required Section 8 declaration was not filed. The registration covered a broad set of services in classes 035 (management and operation of telephone call centers and administration of patient reimbursement programs), 036 (insurance‑related information and grant‑making for patients and research), 041 (training on specialized drug administration techniques), 042 (biotechnology research and consulting), 044 (health‑care information and monitoring services), and class 005 (pharmaceutical preparations for a wide range of central and peripheral nervous system conditions and other medical uses). A similar name used for services in any of those areas would raise the closest record‑based concern, while uses outside those classes would be farther from the scope shown here. The record does not give the owner control over every possible use of the words “reimbursement concierge services.” No enforcement actions such as oppositions or cancellations appear in the history. I'd treat this as a meaningful concern if you plan to offer comparable call‑center or patient‑support services under a similar name.
Informational only - not legal advice.Mark Trademark, Service Mark
| Drawing type | 4 - STANDARD CHARACTER MARK |
| Filing basis | Foreign Registration (§44(e)). |
| Status | Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Key dates
| Application filed | Mar 08, 2012 |
| Published for opposition | Dec 11, 2012 |
| Registered (Principal) | Feb 26, 2013 |
| Status date | Sep 27, 2019 |
Goods & services
Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer, namely, tumor suppressing agents; antibiotics, antifungals, anti-viral drugs; vaccines for the treatment of infectious diseases; diagnostic preparations for medical purposes for use in testing urine, fecal occult blood and other blood diseases, namely, anemia, leukemia, hemophilia; pharmaceuticals for human use, namely, anthelmintics; sanitary preparations, namely, germicides
Management of telephone call centers for others; operation of telephone call centers for others; administration of patient reimbursement programs in order to assist patients in obtaining reimbursements from insurers of health care costs
Insurance agencies excluding life insurance agencies; providing information on Insurance matters; providing grants to patients and their families for improving their quality of life; providing grants to medical research organizations and business associations in support of scientific, medical and business meetings and workshops; providing grants to educational institutions and research organizations in support of educating the public about medical issues
Educational services, namely, providing training and instruction in the use of specialized drug administration techniques and conducting seminars in the medical field
Research and consultation services in the field of biotechnology
Providing health care services, namely, providing health care information to patients by means of a toll-free telephone number, medical evaluation services, namely, assessment program for patients receiving drug treatment services for the purpose of monitoring patient's compliance with drug procedures and providing medical advisory services related thereto
Owner & representation
| Owner | Astellas Pharma Inc. |
| Address | 3-11, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo JAPAN |
| Entity | CORPORATION - organized in JAPAN |
| Attorney of record | Kaushal R. Odedra |
| Correspondent | KAUSHAL R. ODEDRA |
| Attorney email | K********@*****.com |
| Correspondent email | K********@*****.com |
| Correspondent phone | 2********0 |
| Correspondent address | WASHINGTON, DISTRICT |